Indications for ENSTILAR:

Plaque psoriasis.


Apply to affected areas once daily for up to 4 weeks; discontinue when control is achieved. ≥18yrs: max 60g every 4 days. Do not occlude.


<18yrs: not studied.


Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, or irritation occurs. Do not use on face, axillae, or groin, or if atrophy is present at treatment site. Avoid eyes, sun, UV light (eg, phototherapy). Flammable. Allergic contact dermatitis. Pregnancy (Cat.C). Nursing mothers.

Pharmacologic Class:

Vit. D3 derivative + topical steroid.


Systemic absorption potentiated by other corticosteroids.

Adverse Reactions:

Application site irritation and pruritus, folliculitis, skin hypopigmentation, hypercalcemia, urticaria, psoriasis exacerbation.

How Supplied:

Foam (60g)—1, 2

Pricing for ENSTILAR

60g foam of 0.005%/0.064% carton (Qty: 1)
Appx. price $1049